Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Immuno-Oncology Overview 2017: CAR-T Cell Therapy Early Clinical Results are Extremely Promising - ResearchAndMarkets.com

Research and Markets
Posted on: 15 Feb 18

The "Immuno-Oncology Overview" report has been added to ResearchAndMarkets.com's offering.

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well as one of the most active areas in terms of licensing deals and acquisitions.

Highlights

  • The PD-1/PD-L1 inhibitor and TCR/CAR-T therapy drug classes lead the development of all immuno-oncology drugs. However, several novel mechanisms of action are also in early-phase development.
  • Developers of approved PD-1/PD-L1 inhibitors - Bristol-Myers Squibb, Merck & Co, Roche, AstraZeneca, and Pfizer - currently dominate the immuno-oncology field in terms of the number of ongoing, conducted, and planned trials.
  • Furthermore, PD-1/PD-L1 inhibitors remain a focal point of immuno-oncology combinations, with various types of combination approaches being studied.

Key Topics Covered:

  1. Executive Summary
  2. Immuno-Oncology Overview
  3. Current Status Of Immuno-Oncology Development
  4. Pd-1/Pd-L1 Inhibitors
  5. Ctla-4 Inhibitors
  6. Tcr And Car-T Therapies
  7. Ido Inhibitors
  8. Emerging Drug Classes
  9. Bristol-Myers Squibb
  10. Merck & Co
  11. Roche
  12. Astrazeneca
  13. Pfizer
  14. Immuno-Oncology Combinations
  15. Kol Survey
  16. Kol Interviews

For more information about this report visit https://www.researchandmarkets.com/research/mx83p9/immunooncology?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180215005540/en/

Business Wire
www.businesswire.com

Last updated on: 15/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.